WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000058360) ANALOGS OF GASTRIC INHIBITORY PEPTIDE AND THEIR USE FOR TREATMENT OF DIABETES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/058360    International Application No.:    PCT/GB2000/001089
Publication Date: 05.10.2000 International Filing Date: 29.03.2000
Chapter 2 Demand Filed:    21.09.2000    
IPC:
A61K 38/00 (2006.01), C07K 14/575 (2006.01)
Applicants: UUTECH LIMITED [GB/GB]; University House, Cromore Road, Coleraine, Northern Ireland, BT52 1SA (GB) (For All Designated States Except US).
O'HARTE, Finbarr, Paul, Mary [GB/GB]; (GB) (For US Only).
FLATT, Peter, Raymond [GB/GB]; (GB) (For US Only)
Inventors: O'HARTE, Finbarr, Paul, Mary; (GB).
FLATT, Peter, Raymond; (GB)
Agent: MURGITROYD & COMPANY; 373 Scotland Street, Glasgow G5 8QA (GB)
Priority Data:
9907216.7 29.03.1999 GB
9917565.5 27.07.1999 GB
Title (EN) ANALOGS OF GASTRIC INHIBITORY PEPTIDE AND THEIR USE FOR TREATMENT OF DIABETES
(FR) PEPTIDE
Abstract: front page image
(EN)The present invention provides peptides which stimulate the release of insulin. The peptides, based on GIP 1-42 include substitutions and/or modifications which enhance and influence secretion and/or have enhanced resistance to degradation. The invention also provides a process of N terminally modifying GIP and the use of the peptide analogues for treatment of diabetes.
(FR)L'invention concerne des peptides qui stimulent la libération d'insuline. Ces peptides, basés sur GIP 1-42 comprennent des substitutions et/ou des modifications qui améliorent et influencent la sécrétion et/ou présentent une résistance améliorée à la dégradation. L'invention concerne également un procédé permettant de modifier la terminaison N de GIP ainsi que l'utilisation d'analogues peptidiques afin de traiter le diabète.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)